Seattle, July 18, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global ENT disorder treatment market is estimated to be valued at US$ 11,219.19 million in 2022 and is expected to exhibit a CAGR of 3.3% during the forecast period (2022-2030).
Key Trends and Analysis of the Global ENT Disorder Treatment Market:
Key players are focusing on developing and updating their products with new technologies to treat various types of infection related to ear, nose, and throat. Market players are conducting clinical trials and a large number of treatment drugs and devices are in pipeline for approvals. For instance, in February 2018, Tusker Medical, a medical platform focused on delivering innovative technology to ear, nose, and throat surgeons and their patients announced their first patient enrollment for pivotal clinical trial for tympanostomy tube replacement that is performed for recurrent ear infections or persistent fluid in the middle ear.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1326
The global ENT disorder treatment market is expected to exhibit a CAGR of 3.3% during the forecast period due to the increasing approval of new drugs. For instance, in March 2022, molnupiravir (Lagevrio), an oral antiviral medicine, was listed on the General Schedule (S85) as Authority Required (Streamlined) for specific patient groups with mild-to-moderate COVID-19 at high risk of severe disease. It is the first treatment listed on the Pharmaceutical Benefits Scheme (PBS) for COVID-19.
Among end users, hospital segment holds a dominant position in the global ENT disorder treatment market, as most of the surgical, non-surgical as well as consultation procedures are conducted at hospitals. For instance, in July 2018, according to National Center for Biotechnology information, the American Academy of Otolaryngology- a tonsillectomy is a surgical procedure performed with or without adenoidectomy that completely removes the tonsil, including its capsule, by dissecting the peritonsillar space between the tonsil capsule and the muscular wall. In the U. S., tonsillectomy is one of the most commonly performed surgical procedures. Over 500,000 cases are performed annually in children less than 15 years of age in the U.S.
Key players operating in the global ENT disorder treatment market include Sanofi, AstraZeneca plc, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc., Merck & Co., Dr. Reddys Laboratories Ltd., Allergan plc, Cochlear Ltd., Sonova Holding AG, Siemens Healthcare, Starkey Laboratories Inc., William Demant Holding A/S, Widex A/S, GN ReSound A/S, Sonic Innovations Inc., Panasonic Corp., Beltone, Rexton Inc., Avada Hearing Care, Miracle-Ear Inc., MED-EL GmbH, Nuear Hearing Aids Inc., Audiosync Inc., Bernafon, American Hearing Systems Inc., Unitron Hearing Inc., and Zounds Inc.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1326
Global ENT Disorder Treatment Market, By Treatment Type:
Global ENT Disorder Treatment Market, By Organ Type:
Global ENT Disorder Treatment Market, By End User:
Global ENT Disorder Treatment Market, By Region:
Medical Ozone Generator Market, by Type (Trolley-mounted and Table-top), by Application (Oncological Treatment, Dermatological Treatment, Gastrointestinal Treatment, Dental Treatment, Gynecologic Treatment, and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028
Medical Cyclotron Market, by Product Type (Fixed Energy Cyclotron and Variable Energy Cyclotron (10-30 MeV and 30-70 MeV)), by Application (Diagnostic and Treatment and Research and Development), by End User (Hospitals, Diagnostic Centers, Commercial Radioisotope Manufacturers, and Research and Academic Institutes) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Follow Us: LinkedIn | Twitter
The company had said it was in talks with the FDA about seeking early approval, but Wall Street analysts thought the agency would make it wait to apply.
We just can't get a break from COVID. While things were inching closer towards normalcy, cases are rising again thanks to the latest dominant variant BA.5, which experts say is the most contagious COVID strain yet. Although the virus affects everyone differently, there are symptoms to watch out for that indicate you've had COVID and Eat This, Not That! Health spoke with Dr. Mark Fischer, Regional Medical Director at International SOS who explains what to know about BA.5 and symptoms to watch out
The Biden administration said it would spend $1.74 billion to buy 66 million doses of Moderna updated Covid-19 vaccine, as well as the option to purchase up to 234 million additional doses, as part of a fall booster campaign. The deal Friday, which follows an agreement to buy 105 million doses of updated vaccines from Pfizer and partner BioNTech SE is expected to give the federal government enough shots for a booster push as early as September. Under the latest deal, the U.S. government has the option to buy up to an additional 234 million doses from Moderna.
A federal court ruling has dealt a blow to Bausch Health by appearing to clear the way for generic competition for the company’s drug Xifaxan. Bausch Health stock (ticker: BHC) plummeted more than 50% Thursday morning on the news, and trading of the shares was halted. In 2020, Bausch Health Ireland and Salix Pharmaceuticals sued Norwich Pharmaceuticals in 2020 for patent infringement, regarding Norwich’s plans to bring a generic version of Xifaxan to market before its patents had expired, according to a Bloomberg Law report.
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis and cannabinoid-based consumer product company, today announced several new additions to its premium flower portfolio. Perfect for both staycations and weekends away, the new premium flower offerings from 7ACRES and Doja demonstrate Canopy Growth's commitment to continued innovation and strengthen its leading position in the premium flower category.
Dementia is a brain disorder that affects an estimated 55 million people worldwide according to the World Health Organization. The condition is becoming more common and while age is a leading risk factor, people under 65 can also have dementia, which causes memory loss, mood changes, getting lost in familiar places and more. Being aware of other risk factors like lack of sleep, poor diet, social isolation and not enough exercise can make a difference, but so does knowing your blood type, accordi
AstraZeneca's Covid-19 antibody drug slashes the risk of new variants emerging, the company said, as Britain faces mounting pressure to follow other Western nations in ordering doses.
The chiropractor told her mother that she was ‘having a reaction to the treatment.’”
It's make-or-break time for Neurocrine Biosciences' essential tremors treatment, analysts say, as NBIX stock trends sideways.
More research suggests it’s time to abandon the craze over vitamin D. Taking high doses of “the sunshine vitamin” doesn't reduce the risk of broken bones in generally healthy older Americans, researchers reported Wednesday. An estimated third of Americans 60 and older take the supplements and more than 10 million blood tests for vitamin D levels are performed annually -- despite years of controversy over whether the average older adult needs either.
The number of new monkeypox cases in the Commonwealth continue to climb.
The U.S. government has secured 66 million doses of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine booster candidate, mRNA-1273.222, a bivalent booster candidate containing Spikevax plus the omicron BA.4/5 strain mRNA. The contract includes an award of up to $1.74 billion for manufacturing and delivering 66 million doses of mRNA-1273.222 and options to purchase up to an additional 234 million doses of COVID-19 vaccine booster candidates. In June, Moderna released new data showing that one month a
No matter how much we wish it were, the pandemic is certainly not over. COVID cases, deaths, and hospitalizations are all on the rise in the U.S., "driving COVID-19 community levels up to medium or high in 75 percent of counties," according to the Centers for Disease Control and Prevention (CDC). Two new and highly evolved versions of the virus now make up around 95 percent of COVID cases in the country—Omicron subvariants BA.5 and BA.4. But it's not just the name that's changed: These subvarian
Three weeks before the Supreme Court overturned Roe v. Wade, Dr. Caitlin Bernard, an Indianapolis obstetrician-gynecologist, donned her white lab coat, put her infant daughter into a front-pack baby carrier and joined a few colleagues who marched to the state Capitol, hoping to deliver a letter to Gov. Eric Holcomb. Signed by hundreds of health professionals, the letter implored Holcomb, a Republican, not to convene a special legislative session to further restrict abortions. It contained a poin
Deciding between oat milk and almond milk? Here, nutritionists explain the differences, benefits, pros and cons, and nutrition of both plant-based milks.
Breast explant surgery inquiries have been on the rise. These women share why.
The NHS could be banned from giving puberty blockers to children amid concerns that youngsters are being “rushed” into changing their gender.
Some firms like Pfizer are already looking beyond BA.5 to a universal vaccine.
Monkeypox has spread across multiple countries, including the U.S., where the Centers for Disease Control and Prevention (CDC) has confirmed almost 5,000 cases since May. While reminiscent of the beginning of the COVID-19 pandemic, this viral disease spreads differently. We all remember masking up, wearing gloves, and waiting in line to get into the grocery store in 2020, but will we have to do that again because of this virus?Experts at the CDC and others say monkeypox spreads mostly through cl